Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
91.27
+0.69 (0.76%)
At close: Aug 14, 2026, 4:00 PM EDT
90.83
-0.44 (-0.48%)
Pre-market: Aug 17, 2026, 6:40 AM EDT
Medtronic Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
| 36,364 | 33,537 | 32,364 | 31,227 | 31,686 | |
Revenue Growth | 8.43% | 3.62% | 3.64% | -1.45% | 5.21% |
Cost of Revenue | 12,615 | 11,606 | 11,091 | 10,622 | 10,028 |
Gross Profit | 23,749 | 21,931 | 21,273 | 20,605 | 21,658 |
Selling, General & Admin | 11,686 | 10,748 | 10,521 | 10,237 | 10,047 |
Research & Development | 2,873 | 2,732 | 2,735 | 2,696 | 2,746 |
Amortization of Goodwill & Intangibles | 1,893 | 1,958 | 1,693 | 1,698 | 1,733 |
Other Operating Expenses | 31 | 159 | -506 | 405 | 285 |
Operating Expenses | 16,483 | 15,597 | 14,443 | 15,036 | 14,811 |
Operating Income | 7,266 | 6,334 | 6,830 | 5,569 | 6,847 |
Interest Expense | -715 | -729 | -719 | -583 | -553 |
Interest & Investment Income | 383 | 511 | 597 | 386 | 186 |
Currency Exchange Gain (Loss) | -182 | 306 | 176 | 672 | 198 |
Other Non Operating Income (Expenses) | 341 | 363 | -73 | 124 | 36 |
EBT Excluding Unusual Items | 7,093 | 6,785 | 6,811 | 6,168 | 6,714 |
Merger & Restructuring Charges | -370 | -303 | -828 | -645 | -1,110 |
Impairment of Goodwill | - | - | - | -61 | - |
Gain (Loss) on Sale of Investments | -421 | -565 | -220 | - | 8 |
Gain (Loss) on Sale of Assets | - | - | - | -75 | - |
Asset Writedown | 121 | 151 | - | - | - |
Legal Settlements | -113 | -317 | -149 | 30 | -95 |
Other Unusual Items | -173 | -124 | -777 | -53 | - |
Pretax Income | 6,137 | 5,627 | 4,837 | 5,364 | 5,517 |
Income Tax Expense | 1,299 | 936 | 1,133 | 1,580 | 456 |
Earnings From Continuing Operations | 4,838 | 4,691 | 3,704 | 3,784 | 5,061 |
Minority Interest in Earnings | -37 | -29 | -28 | -26 | -22 |
Net Income | 4,801 | 4,662 | 3,676 | 3,758 | 5,039 |
Net Income to Common | 4,801 | 4,662 | 3,676 | 3,758 | 5,039 |
Net Income Growth | 2.98% | 26.82% | -2.18% | -25.42% | 39.74% |
Shares Outstanding (Basic) | 1,282 | 1,286 | 1,328 | 1,330 | 1,342 |
Shares Outstanding (Diluted) | 1,288 | 1,290 | 1,330 | 1,333 | 1,351 |
Shares Change | -0.14% | -3.03% | -0.19% | -1.38% | -0.19% |
EPS (Basic) | 3.75 | 3.63 | 2.77 | 2.83 | 3.75 |
EPS (Diluted) | 3.73 | 3.61 | 2.76 | 2.82 | 3.73 |
EPS Growth | 3.32% | 30.80% | -2.13% | -24.40% | 40.23% |
Free Cash Flow | 5,426 | 5,185 | 5,200 | 4,580 | 5,978 |
Free Cash Flow Per Share | 4.21 | 4.02 | 3.91 | 3.44 | 4.42 |
Dividend Per Share | 2.840 | 2.800 | 2.760 | 2.720 | 2.520 |
Dividend Growth | 1.43% | 1.45% | 1.47% | 7.94% | 8.62% |
Gross Margin | 65.31% | 65.39% | 65.73% | 65.98% | 68.35% |
Operating Margin | 19.98% | 18.89% | 21.10% | 17.83% | 21.61% |
Profit Margin | 13.20% | 13.90% | 11.36% | 12.03% | 15.90% |
Free Cash Flow Margin | 14.92% | 15.46% | 16.07% | 14.67% | 18.87% |
EBITDA | 10,103 | 9,044 | 9,477 | 8,266 | 9,554 |
EBITDA Margin | 27.78% | 26.97% | 29.28% | 26.47% | 30.15% |
D&A For EBITDA | 2,837 | 2,710 | 2,647 | 2,697 | 2,707 |
EBIT | 7,266 | 6,334 | 6,830 | 5,569 | 6,847 |
EBIT Margin | 19.98% | 18.89% | 21.10% | 17.83% | 21.61% |
Effective Tax Rate | 21.17% | 16.63% | 23.42% | 29.46% | 8.27% |